Part of
the purchase price of the Shares was obtained through margin borrowing.
The aggregate
purchase price of the Shares purchased by the Reporting Persons collectively was approximately $ 229 million (including commissions and premiums for options to purchase Shares).
The purchase price of the shares will be 85 % of the lower of the fair market value of our Class A common stock on the first trading day of each offering period or on the exercise date.
The purchase price of each Share will be (i) not less than the net asset...
The purchase price of each Share will be (i) not less than the net asset value per Share (the «NAV Per Share») of the Company's common stock (as determined in good faith by the board of directors of the Company or a committee thereof, in its sole discretion) immediately prior to the Expiration Date (as defined in the Offer to Purchase)(the date of repurchase) and (ii) not more than 2.5 % greater than the NAV Per Share as of such date, plus any unpaid dividends accrued through the expiration date of the Tender Offer.
The purchase price of the shares will be 85 % of the lower of the fair market value of our common stock on the first trading day of the offering period or on the last day of the offering period.
The purchase price of the shares will be 85 % of the lower of the fair market value of our common stock on the first trading day of each offering period or on the exercise date.
The purchase price of each Share will be (i) not less than the net asset... Read More... Read More
Determine FIF status - In order for the FIF taxation rules to apply to individuals, the cost price of offshore investments must exceed a prescribed threshold amount defined as the total
purchase price of all shares.
It is only when you sell the mutual fund shares (back to the mutual fund company) that you have to pay taxes on the capital gains (if you sold for a higher price) or deduct the capital loss (if you sold for a lower price) than
the purchase price of the shares.
With the Single Category method, you add up
the purchase prices of all your shares and divide by the total.
As a value investor, you should know that your success will be fully dependent on the accuracy of your answers on simple questions like what is the real value of a specific company and if whether the actual intrinsic value is lesser than the total
purchase price of the shares.
While
the purchase price of the shares will not likely be identical for each transaction, it is also unlikely that they will differ significantly over such a short time frame.
Not exact matches
T. Rowe dropped Dropbox
shares by 16 percent, meaning the current value
of its holdings in that company is reportedly under water — 13 percent below the firm's original
purchase price in 2012.
HOUSTON, April 20, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the closing
of its previously announced underwritten public offering
of 9,200,000
shares of its common stock, including 1,200,000
shares sold pursuant to the underwriters» full exercise
of their option to
purchase additional
shares, at a public offering
price of $ 7.50 per
share.
And the company could theoretically pull off such a
purchase; the
share price of Netflix has nosedived more than 60 % since its high in July, with a corresponding reduction in market cap.
This agreement provides for the
purchase of the deceased partner's
share of the business at a prearranged
price.
When you
purchase a broad swath
of equities, say an S&P 500 index fund, the returns you can expect over the next decade or so comprise four building blocks: the starting dividend yield, projected growth in real earnings per
share, expected inflation, and the expected change in «valuation» — that is, the expansion or contraction in the
price / earnings (P / E) multiple.
And yet, buried in a footnote in Siebel's latest 10 - K filing is the fact that the company has granted options to employees to buy 9.8 million
shares at an average
purchase price of $ 6.46.
Though the IPO only gave Rovio half the market value the company had hoped for ($ 900 million ($ 1.1 billion) instead
of its anticipated $ 2 billion), stock bounced back when a bank backing the IPO started
purchasing shares to «stabilize» the
price, according to Bloomberg.
Similarly, the volume simply converted based on the current
share price is expected to reach a total
of 2.37 million
shares consisting
of the existing 1.61 million ordinary
shares (2.04 million before division) and 0.76 million
shares to be additionally
purchased and retired.
Meanwhile, in June, New York City's Blue Apron was forced to revise its initial
share price, following news that Amazon intended to enter the sector just after its $ 13.7 billion
purchase of Whole Foods.
As well, NAC has issued to Second Cup warrants to
purchase 5,000,000 common
shares of the company, at an exercise
price of 91 cents per
share.
Stock options allow employees to
purchase shares in their company at a
price fixed when the optionis granted (the grant
price) for a defined number
of years into the future.
Bellicum expects to grant the underwriters
of the offering a 30 - day option to
purchase up to an additional 1,050,000
shares of its common stock at the public offering
price, less the underwriting discounts and commissions.
One trade the SEC is looking at took place at 12:06 p.m. on that day, when there was a
purchase of options with the rights to buy 200,000
shares of BlackBerry stock at a strike
price of $ 10 a
share, the person said.
Instead, if the investor is
purchasing $ 5,000 worth
of stock at a warrant - conversion
price of $ 2,000, the company subtracts the cost
of the conversion and actually turns over only $ 3,000 worth
of shares to its investor.
HPE will pay $ 12.50 per
share in cash, representing a net cash
purchase price at closing
of $ 1.0 billion.
The
purchase gave another boost to the company's
share price, which had already gone from $ 40 to over $ 60 in 2014, with a full year total stockholder return
of 64 %.
There were also employee
share options outstanding to
purchase up to an additional 3.4 million
shares, at a weighted average exercise
price of $ 31.37 per
share, 0.8 million
of which were fully vested; equity - settled
share appreciation rights (SARs) for 0.2 million
shares, at a weighted average measurement
price of $ 32.18, all
of which, excluding SARs for approximately 1,000
shares, were fully vested; and restricted
share units (RSUs) covering 13.0 million
shares,
of which RSUs to acquire 4.3 million
shares were fully vested.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP
purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market
share and
price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering
prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its
share repurchase program due to changes in its stock
price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
In addition to falling
share prices and a lack
of purchase offers, BlackBerry has also had to make staffing cuts.
Camber Capital Management, a hedge fund with an activist history, has
purchased 5.7 million
shares of Tenet Healthcare Corp., or a 5.7 % stake in the money - losing hospital chain.The emergence
of Camber was disclosed Monday, just three days after Tenet's largest shareholder, Glenview Capital Management, resigned two Tenet board seats, citing irreconcilable differences with management and the board.Glenview Capital, which owns an 18 % stake in Tenet, gave notice Friday that it would no longer participate in a stand - still agreement that had prevented it from launching a proxy fight for control
of the company.Tenet investors welcomed the Camber disclosure Monday, driving up Tenet's stock
price to $ 2.18, or 15 %, to $ 16.63 as
of 12:30 p.m. ET.Tenet is the nation's third - largest investor - owned
UNDERWRITING: $ 572,000 Multicom's lead underwriter, Laidlaw Equities Inc., in New York City,
priced the securities at $ 6.50 a
share and
purchased 345,000
of the 1.1 million total
shares from Multicom.
If you
purchase shares of our common stock in this offering, you will experience immediate and substantial dilution
of $ in the net tangible book value per
share, assuming an initial public offering
price of $ per
share (the midpoint
of the
price range set forth on the front cover
of this prospectus).
If the market
price of our common stock declines significantly, you may be unable to resell your
shares at or above your
purchase price, if at all.
Should the deal's underwriters exercise an option to
purchase up to 2.4 million additional
shares, Ardagh said it could raise as much as $ 372.6 million (352.2 million euros) at the top
of its
price range.
However,
Shares used to pay the exercise
price or
purchase price of an option or stock appreciation right or to satisfy tax withholding obligations relating to such awards do not become available for future issuance under the 2013 Plan.
If you are able to sell your
shares of common stock, you will likely receive less than your
purchase price.
From January 1, 2008 through December 31, 2010, the Registrant granted to its employees, consultants and other service providers options to
purchase an aggregate
of 12,566,833
shares of common stock under the Registrant's Amended and Restated 2003 Stock Incentive Plan, or the 2003 Plan, at exercise
prices ranging from $ 1.50 to $ 14.46 per
share, which includes options to
purchase shares of common stock that were repriced on a one - for - one basis to $ 2.32 per
share in February 2009.
5,800,200
shares of our Class B common stock issuable upon the exercise
of options to
purchase shares of our Class B common stock granted after June 30, 2015, with a weighted - average exercise
price of $ 15.23 per
share;
Therefore, if you
purchase shares of our Class A common stock in this offering, you will experience immediate dilution
of $ per
share, the difference between the
price per
share you pay for our Class A common stock and its pro forma net tangible book value per
share as
of September 30, 2010, after giving effect to the issuance
of shares of our Class A common stock in this offering.
From January 1, 2008 through December 31, 2010, the Registrant granted to certain executive officers, directors and other investors options and rights to
purchase an aggregate
of 8,196,662
shares of common stock under the 2003 Plan at exercise
prices ranging from $ 2.00 to $ 6.20 per
share, which includes options to
purchase shares of common stock that were repriced on a one - for - one basis to $ 2.32 per
share in February 2009.
The Compensation Committee believes that options to
purchase shares of our common stock, with an exercise
price equal to the market
price of our common stock on the date
of grant, are inherently performance - based and are a very effective tool to motivate our executives to build stockholder value and reinforce our position as a growth company.
a. I can do nothing and I'll be required to
purchase 100
shares of said security at the strike
price.
Shares used to pay the
purchase price or satisfy tax withholding obligations
of awards other than stock options or stock appreciation rights become available for future issuance under the 2013 Plan.
106,133,176
shares of our Class B common stock issuable upon the exercise
of options to
purchase shares of our Class B common stock outstanding as
of September 30, 2015, with a weighted - average exercise
price of $ 6.95 per
share;
The founders
of a startup generally
purchase shares at the time
of incorporating the company at a nominal
price per
share, such as $ 0.0001 per
share, paid in cash, since at that time the company will have no operating history, few assets and thus little value.
That October, Buffett exercised all
of its warrants to
purchase 10.7 million
shares of GE's common stock, a position valued at $ 264.76 million based on the closing
price on the date the
shares were delivered.
From July 2012 through September 2012, the Registrant sold an aggregate
of 20,164,210
shares of its Series D convertible preferred stock to 21 accredited investors at a
purchase price of approximately $ 11.014 per
share, for an aggregate
purchase price of approximately $ 222.1 million.